PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Primary care-based weight intervention helps obese patients reduce weight

10-pound weight loss achieved at 2 years in Penn's POWER-UP study

2011-11-15
(Press-News.org) PHILADELPHIA – Can a visit to your primary care doctor help you lose weight? Primary care physicians, working with medical assistants in their practices, helped one group of their obese patients lose an average of 10.1 lb during a two-year lifestyle intervention, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Their 10 lb weight loss was associated, over the two years, with improvements in cardiovascular disease (CVD) risk factors, including waist circumference and HDL cholesterol levels. The results of the POWER-UP (Practice-based Opportunities for Weight Reduction at the University of Pennsylvania) trial were reported in the latest edition of the New England Journal of Medicine and at the American Heart Association annual meeting today.

"The enhanced lifestyle counseling program offers a successful model for treating obesity in primary care practice with the support of regular staff members – primary care providers (PCPs) and medical assistants," said POWER-UP principal investigator Thomas A. Wadden, PhD, professor of Psychology in Psychiatry at Penn's Perelman School of Medicine and director of the Penn Center for Weight and Eating Disorders. "This is an important finding, in light of the Centers for Medicare and Medicaid Services' recent proposal to cover the costs of intensive behavioral weight loss counseling provided to seniors in primary care practice by physicians and nurse practitioners," Dr. Wadden added.

The study compared three interventions - usual care (which consisted of quarterly PCP visits alone), brief lifestyle counseling (which included quarterly PCP visits plus brief, monthly weight loss visits with a medical assistant), and enhanced brief lifestyle counseling which added options for using readily-available meal replacements or a weight loss medication. The majority of participants chose to use meal replacements.

Of the 390 participants, who had an average starting weight of 237 lb, the average weight loss at two years was 3.7 lb with usual care, 6.4 lb with brief lifestyle counseling, and 10.1 lb with enhanced lifestyle counseling. Thirty-five percent of the enhanced lifestyle group lost 5 percent or more of their initial body weight, compared to 22 and 26 percent in the usual care and brief lifestyle groups, respectively.

The study was conducted at six primary care practices owned by Penn Medicine. Only one of the PCPs, and none of the medical assistants, had significant prior experience with weight management. They all received 6-8 hours of training and followed written treatment protocols during the study. The PCPs met with all patients quarterly, and devoted 5-7 minutes of the visit to providing information about weight control.

"We were pleased that PCPs, by just briefly discussing weight management at quarterly visits, could help one fifth of their obese patients in the usual care group lose 5 percent or more of initial weight, a marker of clinically significant weight loss," said Wadden.

The monthly lifestyle counseling sessions, conducted by medical assistants, began with a weigh-in, followed by an examination of participants' food and exercise diaries and the review of abbreviated lessons from the Diabetes Prevention Program, a previously developed intervention for diet and activity modification in overweight individuals. Participants in the enhanced lifestyle group also discussed their adherence to the meal replacements or weight loss medication. Participants chose between meal replacements and medications in consultation with their PCPs and were only allowed one option at a time (which they could switch with their PCP's agreement).

###The study was part of the $17.5 million Practice-based Opportunities for Weight Reduction or POWER Trials funded by the NIH's National Heart, Lung, and Blood Institute (NHLBI). Three five-year, randomized, controlled clinical trials, each conducted at a different institution, sought to identify effective weight loss treatments that could be used in routine primary care practices to help obese patients who had at least one risk factor for cardiovascular disease.

In addition to Dr. Wadden, the POWER-UP study team from Penn included Sheri Volger, MS, RD; David Sarwer, PhD; Marion Vetter, MD, RD; Robert Berkowitz, MD; Shiriki Kumanyika, PhD, MPH; Kathryn Schmitz, PhD, MPH; Lisa Diewald, MS, RD; Ronald Barg, MD; Jessie Chittams, MS; and Renee More, PhD; representing Penn's Departments of Psychiatry, Surgery, Medicine and the Center for Clinical Epidemiology and Biostatistics, as well as the Department of Child and Adolescent Psychiatry at the Children's Hospital of Philadelphia.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4 billion enterprise.

Penn's Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools and among the top 10 schools for primary care. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $507.6 million awarded in the 2010 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2010, Penn Medicine provided $788 million to benefit our community.


ELSE PRESS RELEASES FROM THIS DATE:

Aiken & Scoptur Recognized in U.S. News - Best Lawyers Rankings

Aiken & Scoptur Recognized in U.S. News - Best Lawyers Rankings
2011-11-15
The plaintiffs' law firm of Aiken & Scoptur, S.C., has been included in the first-tier rankings for medical malpractice law in Milwaukee and personal injury in Milwaukee in the 2011-2012 U.S. News - Best Lawyers "Best Law Firms" rankings. The rankings are based upon a thorough evaluation process involving reviews by clients and peers, as well as other information. The qualities considered include responsiveness, expertise, integrity and cost-effectiveness. Clients and other lawyers were also asked whether they would refer a matter to the firm. Ratings ...

Text4baby mobile service shows positive results for new moms

2011-11-15
Researchers at UC San Diego Health System's Department of Reproductive Medicine and the National Latino Research Center (NLRC) at Cal State San Marcos University recently presented data at the American Public Health Association Conference in Washington D.C., demonstrating the impact of text4baby, a free mobile service that provides pregnant women and new mothers in San Diego with maternal, fetal and newborn health information via text messages and connects them to national health resources. The study, funded by the Alliance Healthcare Foundation, took place with text4baby ...

Fetal stem cells from placenta may help maternal heart recover from injury

2011-11-15
Researchers from Mount Sinai School of Medicine have discovered the therapeutic benefit of fetal stem cells in helping the maternal heart recover after heart attack or other injury. The research, which marks a significant advancement in cardiac regenerative medicine, was presented today at the American Heart Association's (AHA) Scientific Sessions 2011 in Orlando, Florida, and is also published in the current issue of Circulation Research, a journal of the AHA. In the first study of its kind, the Mount Sinai researchers found that fetal stem cells from the placenta migrate ...

Evidence emerges of ancient lake in California's Eel River

2011-11-15
A catastrophic landslide 22,500 years ago dammed the upper reaches of northern California's Eel River, forming a 30-mile-long lake which has since disappeared. It left a living legacy found today in the genes of the region's steelhead trout. Using remote-sensing technology known as airborne Light Detection and Ranging (LiDAR) and hand-held global-positioning-systems (GPS) units, scientists recently found evidence for a late Pleistocene, landslide-dammed lake along the river. Today the Eel river is 200 miles long, carved into the ground from high in the California Coast ...

The first step to change: Focusing on the negative

2011-11-15
If you want people to change the current system, or status quo, first you have to get them to notice what's wrong with it. That's the idea behind a new study to be published in Psychological Science, a journal of the Association for Psychological Science, which finds that people pay attention to negative information about the system when they believe the status quo can change. "Take America's educational system. You could find some flaws in that system," says India Johnson, a graduate student at Ohio State University who did the new study with Professor Kentaro Fujita. ...

Erectile dysfunction increases with use of multiple medications

2011-11-15
PASADENA, Calif. -- The use of multiple medications is associated with increased severity of erectile dysfunction, according to a Kaiser Permanente study published online in the British Journal of Urology International. This study surveyed 37,712 ethnically diverse men from Southern California and found that men taking various medications are likely to have more severe ED. This was part of the California Men's Health Study, a multiethnic cohort of men ages 46 to 69 who are members of Kaiser Permanente in California. Information about medication use between 2002 and ...

Vascular risk linked to long-term antiepileptic drug therapy

2011-11-15
New research reveals that patients with epilepsy who were treated for extended periods with older generation antiepileptic drugs (AEDs) may be at increased risk for developing atherosclerosis, a common disorder known as hardening of the arteries. According to the findings now available in Epilepsia, the journal of the International League Against Epilepsy (ILAE), the vascular risk is significantly associated with the duration of AED monotherapy. While the majority of epilepsy patients have good results with treatment, more than 30% of patients continue to have seizures ...

Risk of Injury from Workplace Violence is Serious Issue in New Jersey and Nationwide

2011-11-15
Workplace violence is a serious issue in New Jersey and across the country. Recently adopted federal guidelines attempt to address the problem more comprehensively than in the past. In September 2011, the Occupational Safety and Health Administration (OSHA), the agency responsible for setting and enforcing standards for workplace safety, issued a directive entitled Policies and Procedures for Investigating and Inspecting Incidents of Workplace Violence. The new directive sheds light on how widespread the problem of workplace violence has become, identifies particularly ...

New hi-tech survey accelerates collection of vaccination data

2011-11-15
New technology now makes it possible to collect 'near real-time' data about whether people are having any side effects from vaccination. By studying people who received the 2009-10 swine flu vaccination in Scotland, researchers showed that this rapid reporting can add another layer of safety to future vaccination campaigns. In addition, the data collected revealed no significant safety issues in patients exposed to the vaccine. The project's report has just been published in the British Journal of Clinical Pharmacology. In 2009, the UK Government recommended that some ...

New study finds that PROMETAT, a controversial methamphetamine treatment program, is ineffective

2011-11-15
A recent study has found that PROMETAT, a popular but controversial treatment for methamphetamine addiction, is no more effective than placebo in reducing methamphetamine use, keeping users in treatment, or reducing cravings for methamphetamine. The study was funded by Hythiam, the company that owns the PROMETAT protocol, and is published online today in the scientific journal Addiction. Methamphetamine, also known as meth, crystal meth, or ice, is the second most abused illicit drug in the world (cannabis is first), with 15-16 million regular users. The United States ...

LAST 30 PRESS RELEASES:

Genome Research publishes a Special Issue on Long-read DNA and RNA Sequencing Applications in Biology and Medicine

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Children’s Hospital Colorado Heart Institute earns national recognition for excellence in cardiomyopathy care

Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice

Cigarette smoke alters microbiota, aggravates flu severity

Landmark study reveals over 100,000 American youth living with inflammatory bowel disease

Diverse diets of civets in Borneo rainforest allow them to live in same geographical area

Virtual reality could be gamechanger in police-civilian crisis encounters

Recycled pacemakers function as well as new devices, international study suggests

Researchers eliminate the gritty mouth feel: How to make it easier to eat fiber-rich foods

An innovative antibiotic for drug-resistant bacteria

Garden produce grown near Fayetteville works fluorochemical plant contains GenX, other PFAs

CMU-Africa expands digital public infrastructure initiative across the continent

Study calls for city fashion waste shakeup

Scientists develop breakthrough culture system to unlock secrets of skin microbiome

Masseter muscle volume might be a key indicator of sarcopenia risk in older adults

New study unveils key strategies against drug-resistant prostate cancer

Northwestern Medicine, West Health, Meadows Mental Health Policy Institute collaboration to provide easier access to mental health care

New method reveals DNA methylation in ancient tissues, unlocking secrets of human evolution

Researchers develop clinically validated, wearable ultrasound patch for continuous blood pressure monitoring

Chromatwist wins innovate UK smart grant for £0.5M project

Unlocking the secrets of the first quasars: how they defy the laws of physics to grow

Study reveals importance of student-teacher relationships in early childhood education

Do abortion policy changes affect young women’s mental health?

Can sown wildflowers compensate for cities’ lack of natural meadows to support pollinating insects?

Is therapeutic hypothermia an effective treatment for hypoxic-ischemic encephalopathy, a type of neurological dysfunction in newborns?

Scientists discover the molecular composition of potentially deadly venomous fish

What are the belowground responses to long-term soil warming among different types of trees?

Do area-wide social and environmental factors affect individuals’ risk of cognitive impairment?

UCLA professor Helen Lavretsky reshapes brain health through integrative medicine research

[Press-News.org] Primary care-based weight intervention helps obese patients reduce weight
10-pound weight loss achieved at 2 years in Penn's POWER-UP study